We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current INFIQ market cap is 90.76. The company's latest EPS is USD -0.4889 and P/E is -0.06.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 22.15M | 3.05M | 1.72M | 1.86M | 2.59M |
| Operating Income | -11.93M | -45.66M | -38.5M | -45.08M | -44.84M |
| Net Income | -11.25M | -47.06M | -40.49M | -45.26M | -44.37M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 60.22M | 49.01M | 39.32M | 84.79M | 42.15M |
| Total Liabilities | 7.76M | 41.29M | 62.31M | 63.21M | 61.2M |
| Total Equity | 52.46M | 7.73M | -22.99M | 21.57M | -19.05M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.71M | -41.53M | -35.74M | -40.62M | -42.43M |
| Investing | 13.1M | -12.24M | 14.63M | 5.49M | -55k |
| Financing | 5.62M | 27.73M | 27.44M | 87.11M | 73k |
| Market Cap | 90.76 |
| Price to Earnings Ratio | -0.06 |
| Price to Sales Ratio | 1.05 |
| Price to Cash Ratio | 0.07 |
| Price to Book Ratio | -0.14 |
| Dividend Yield | - |
| Shares Outstanding | 90.76M |
| Average Volume (1 week) | 1.52k |
| Average Volume (1 Month) | 2.6k |
| 52 Week Change | -99.99% |
| 52 Week High | 0.018 |
| 52 Week Low | 0.000001 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Infinity Pharmaceuticals Inc (CE) |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.infi.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
